Literature DB >> 654882

Primary familial amyloidosis with vitreous opacities. Report of an autopsy case.

J Ogata, M Okayama, I Goto, H Inomata, I Yoshida, T Omae.   

Abstract

A 41-year-old Japanese male with a new type of primary familial amyloidosis was reported. The patient developed vitreous opacities, and later, disturbances in the gastrointestinal and nervous systems. At autopsy, amyloid was observed in the vitreous and the retinal vessels. There were extensive cerebral infarcts and heavy meningo-vascular amyloid deposition. Although the postmortem study revealed slight peripheral nerve degeneration in the lower extremities secondary to amyloid deposition, there was no clinical evidence of polyneuropathy.

Entities:  

Mesh:

Year:  1978        PMID: 654882     DOI: 10.1007/BF01273271

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  PORTUGUESE POLYNEURITIC FAMILIAL TYPE OF AMYLOIDOSIS.

Authors:  S HORTAJDA; I FILIPE; S DURANTE
Journal:  Pathol Microbiol (Basel)       Date:  1964

2.  Primary systemic amyloidosis: a review and an experimental, genetic, and clinical study of 29 cases with particular emphasis on the familial form.

Authors:  W D BLOCK; J G CAREY; A C CURTIS; H F FALLS; C E JACKSON; J G RUKAVINA
Journal:  Medicine (Baltimore)       Date:  1956-09       Impact factor: 1.889

3.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

4.  Primary amyloidosis with familial vitreous opacities: an unusual case and family.

Authors:  M Okayama; I Goto; J Ogata; T Omae; I Yoshida; H Inomata
Journal:  Arch Intern Med       Date:  1978-01

5.  Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer.

Authors:  M W Van Allen; J A Frohlich; J R Davis
Journal:  Neurology       Date:  1969-01       Impact factor: 9.910

Review 6.  The genetic amyloidoses with particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type).

Authors:  M Mahloudji; R D Teasdall; J J Adamkiewicz; W H Hartmann; P A Lambird; V A McKusick
Journal:  Medicine (Baltimore)       Date:  1969-01       Impact factor: 1.889

Review 7.  Amyloidosis.

Authors:  A S Cohen
Journal:  N Engl J Med       Date:  1967-09-07       Impact factor: 91.245

8.  Polyneuritic amyloidosis in a Japanese family.

Authors:  S Araki; S Mawatari; M Ohta; A Nakajima; Y Kuroiwa
Journal:  Arch Neurol       Date:  1968-06

9.  Hereditary amyloidosis.

Authors:  C Andrade; S Araki; W D Block; A S Cohen; C E Jackson; Y Kuroiwa; J Nissim; E Sohar; V A McKusick; M W Van Allen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

10.  The genetic aspect of the familial amyloidotic polyneuropathy. Portuguese type of paramyloidosis.

Authors:  C Andrade; M Canijo; D Klein; A Kaelin
Journal:  Humangenetik       Date:  1969
  10 in total
  4 in total

Review 1.  Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.

Authors:  T M Shah; S M Gupta; P Chatterjee; M Campbell; R N Martins
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

2.  A new method to classify amyloid fibril proteins.

Authors:  T Kitamoto; J Tateishi; K Hikita; H Nagara; I Takeshita
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections.

Authors:  H V Vinters; W M Pardridge; D L Secor; N Ishii
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

4.  Novel histochemical approaches to the prealbumin-related senile and familial forms of systemic amyloidosis.

Authors:  T Kitamoto; T Tashima; J Tateishi
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.